These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1343 related items for PubMed ID: 11426967

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Neoadjuvant chemotherapy followed by radical surgery and radiotherapy vs. pelvic irradiation in patients with cervical cancer FIGO stage IIB - IVA.
    Kornovski Y, Gorchev G.
    J BUON; 2006; 11(3):291-7. PubMed ID: 17309152
    [Abstract] [Full Text] [Related]

  • 3. Patterns of spread in node-positive cervical cancer: the relationship between local control and distant metastases.
    Stock RG, Chen AS, Karasek K.
    Cancer J Sci Am; 1996; 2(5):256-62. PubMed ID: 9166542
    [Abstract] [Full Text] [Related]

  • 4. Neoadjuvant chemotherapy and radical surgery compared to radical surgery alone in bulky stage IB-IIA cervical cancer.
    Behtash N, Nazari Z, Ayatollahi H, Modarres M, Ghaemmaghami F, Mousavi A.
    Eur J Surg Oncol; 2006 Dec; 32(10):1226-30. PubMed ID: 16952434
    [Abstract] [Full Text] [Related]

  • 5. [Evaluation of neoadjuvant chemotherapy for locally advanced cervical cancinoma].
    Cheng XD, Lü WG, Ye F, Chen HZ, Xie X.
    Zhonghua Fu Chan Ke Za Zhi; 2006 Feb; 41(2):95-8. PubMed ID: 16640856
    [Abstract] [Full Text] [Related]

  • 6. Type II radical hysterectomy and adjuvant therapy for pelvic lymph node metastasis with stage IB-IIB cervical carcinoma: a retrospective study of 288 patients.
    Zheng M, Huang L, Liu JH, Xiong Y, Li JD, Huang X, He L, Ren YF, Wang HY.
    J Surg Oncol; 2011 Oct; 104(5):480-5. PubMed ID: 21538358
    [Abstract] [Full Text] [Related]

  • 7. Comparative study of bulky stage IB and IA cervical cancer patients treated by radical hysterectomy with and without neoadjuvant chemotherapy: long-term follow-up.
    Manusirivithaya S, Chareoniam V, Pantusart A, Isariyodom P, Srisomboon J.
    J Med Assoc Thai; 2001 Nov; 84(11):1550-7. PubMed ID: 11853297
    [Abstract] [Full Text] [Related]

  • 8. Clinicopathological variables predictive of clinical outcome in patients with FIGO stage Ib2-IIb cervical cancer treated with cisplatin-based neoadjuvant chemotherapy followed by radical hysterectomy.
    Gadducci A, Teti G, Barsotti C, Tana R, Fanucchi A, Orlandini C, Fabrini MG, Genazzani AR.
    Anticancer Res; 2010 Jan; 30(1):201-8. PubMed ID: 20150636
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Neoadjuvant chemotherapy with vincristine and cisplatin followed by radical hysterectomy and pelvic lymphadenectomy for FIGO stage IB bulky cervical cancer: a Gynecologic Oncology Group pilot study.
    Eddy GL, Manetta A, Alvarez RD, Williams L, Creasman WT.
    Gynecol Oncol; 1995 Jun; 57(3):412-6. PubMed ID: 7774847
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Neoadjuvant chemotherapy in stage IB2 squamous cell carcinoma of the cervix.
    Serur E, Mathews RP, Gates J, Levine P, Maiman M, Remy JC.
    Gynecol Oncol; 1997 May; 65(2):348-56. PubMed ID: 9159350
    [Abstract] [Full Text] [Related]

  • 13. Pelvic irradiation with concurrent chemotherapy versus pelvic and para-aortic irradiation for high-risk cervical cancer: an update of radiation therapy oncology group trial (RTOG) 90-01.
    Eifel PJ, Winter K, Morris M, Levenback C, Grigsby PW, Cooper J, Rotman M, Gershenson D, Mutch DG.
    J Clin Oncol; 2004 Mar 01; 22(5):872-80. PubMed ID: 14990643
    [Abstract] [Full Text] [Related]

  • 14. Treatment results of adjuvant chemotherapy after radical hysterectomy for intermediate- and high-risk stage IB-IIA cervical cancer.
    Takeshima N, Umayahara K, Fujiwara K, Hirai Y, Takizawa K, Hasumi K.
    Gynecol Oncol; 2006 Nov 01; 103(2):618-22. PubMed ID: 16777200
    [Abstract] [Full Text] [Related]

  • 15. Histopathological findings in postoperative specimens in cervical cancer patients with stages IB2-IVA after neoadjuvant chemotherapy and preoperative plus postoperative radiotherapy.
    Kornovski Y, Gorchev G.
    J BUON; 2007 Nov 01; 12(1):57-63. PubMed ID: 17436403
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Prognostic factors in patients with bulky stage IB or IIA cervical carcinoma undergoing neoadjuvant chemotherapy and radical hysterectomy.
    Lai CH, Hsueh S, Chang TC, Tseng CJ, Huang KG, Chou HH, Chen SM, Chang MF, Shum HC.
    Gynecol Oncol; 1997 Mar 01; 64(3):456-62. PubMed ID: 9062150
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Clinical behaviors and outcomes for adenocarcinoma or adenosquamous carcinoma of cervix treated by radical hysterectomy and adjuvant radiotherapy or chemoradiotherapy.
    Huang YT, Wang CC, Tsai CS, Lai CH, Chang TC, Chou HH, Lee SP, Hong JH.
    Int J Radiat Oncol Biol Phys; 2012 Oct 01; 84(2):420-7. PubMed ID: 22365621
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 68.